AMRN
Amarin Corporation PLC
NASDAQ: AMRN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$15.02
+0.94% today
Updated 2026-06-05
Market cap
$303.42M
P/E ratio
—
P/S ratio
1.40x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$12 – $21
Volume
0.1M
Amarin Corporation PLC (AMRN) Insider transactions
Net insider activity
Net buying (530,152 shares)
Buy transactions
71
Sell transactions
29
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-18 | SULLIVAN, DIANE E. | Director | Buy | 838 | — | — |
| 2026-04-18 | SULLIVAN, DIANE E. | Director | Buy | 838 | — | — |
| 2026-04-18 | SULLIVAN, DIANE E. | Director | Sale | 403 | $14.98 | $6036.94 |
| 2026-04-18 | STERLING, LOUIS III | Director | Buy | 838 | — | — |
| 2026-04-18 | STERLING, LOUIS III | Director | Buy | 838 | — | — |
| 2026-04-18 | STERLING, LOUIS III | Director | Sale | 403 | $14.98 | $6036.94 |
| 2026-04-18 | ODYSSEAS, KOSTAS D | Director | Buy | 838 | — | — |
| 2026-04-18 | ODYSSEAS, KOSTAS D | Director | Buy | 838 | — | — |
| 2026-04-18 | ODYSSEAS, KOSTAS D | Director | Sale | 403 | $14.98 | $6036.94 |
| 2026-04-18 | O'CONNOR, OLIVER | Director | Buy | 838 | — | — |
| 2026-04-18 | O'CONNOR, OLIVER | Director | Buy | 838 | — | — |
| 2026-04-18 | O'CONNOR, OLIVER | Director | Sale | 438 | $14.98 | $6561.24 |
| 2026-04-18 | HORN, KEITH | Director | Buy | 838 | — | — |
| 2026-04-18 | HORN, KEITH | Director | Buy | 838 | — | — |
| 2026-04-18 | HORN, KEITH | Director | Sale | 403 | $14.98 | $6036.94 |
| 2026-04-18 | COHEN, PAUL | Director | Buy | 838 | — | — |
| 2026-04-18 | COHEN, PAUL | Director | Buy | 838 | — | — |
| 2026-04-18 | COHEN, PAUL | Director | Sale | 403 | $14.98 | $6036.94 |
| 2026-04-18 | BONFIGLIO, PATRICE EADON | Director | Buy | 838 | — | — |
| 2026-04-18 | BONFIGLIO, PATRICE EADON | Director | Buy | 838 | — | — |
| 2026-04-18 | BONFIGLIO, PATRICE EADON | Director | Sale | 403 | $14.98 | $6036.94 |
| 2026-04-01 | FISHMAN, PETER L. | SVP, CFO | Buy | 125 | — | — |
| 2026-04-01 | FISHMAN, PETER L. | SVP, CFO | Buy | 125 | — | — |
| 2026-04-01 | FISHMAN, PETER L. | SVP, CFO | Sale | 62 | $14.46 | $896.52 |
| 2026-02-01 | PROVOOST, JONATHAN | EVP, Chief Legal Officer | Buy | 36,060 | — | — |
| 2026-02-01 | PROVOOST, JONATHAN | EVP, Chief Legal Officer | Buy | 8,013 | — | — |
| 2026-02-01 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 36,060 | — | — |
| 2026-02-01 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 8,013 | — | — |
| 2026-02-01 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 30,060 | — | — |
| 2026-02-01 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 8,013 | — | — |
| 2026-02-01 | FISHMAN, PETER L. | SVP, CFO | Buy | 27,750 | — | — |
| 2026-02-01 | FISHMAN, PETER L. | SVP, CFO | Buy | 6,167 | — | — |
| 2026-02-01 | BERG, AARON | President and CEO | Buy | 120,566 | — | — |
| 2026-02-01 | BERG, AARON | President and CEO | Buy | 26,793 | — | — |
| 2026-01-31 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 2,246 | — | — |
| 2026-01-31 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 1,933 | — | — |
| 2026-01-31 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 2,246 | — | — |
| 2026-01-31 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 1,933 | — | — |
| 2026-01-31 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Sale | 1,235 | $15.42 | $19043.70 |
| 2026-01-31 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Sale | 1,062 | $15.42 | $16376.04 |
| 2026-01-31 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 2,246 | — | — |
| 2026-01-31 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 1,933 | — | — |
| 2026-01-31 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 2,246 | — | — |
| 2026-01-31 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 1,933 | — | — |
| 2026-01-31 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Sale | 1,173 | $15.42 | $18087.66 |
| 2026-01-31 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Sale | 1,010 | $15.42 | $15574.20 |
| 2026-01-31 | FISHMAN, PETER L. | SVP, CFO | Buy | 1,833 | — | — |
| 2026-01-31 | FISHMAN, PETER L. | SVP, CFO | Buy | 563 | — | — |
| 2026-01-31 | FISHMAN, PETER L. | SVP, CFO | Buy | 1,833 | — | — |
| 2026-01-31 | FISHMAN, PETER L. | SVP, CFO | Sale | 1,008 | $15.42 | $15543.36 |
| 2026-01-31 | FISHMAN, PETER L. | SVP, CFO | Buy | 563 | — | — |
| 2026-01-31 | FISHMAN, PETER L. | SVP, CFO | Sale | 310 | $15.42 | $4780.20 |
| 2026-01-31 | BERG, AARON | President and CEO | Buy | 2,246 | — | — |
| 2026-01-31 | BERG, AARON | President and CEO | Buy | 1,933 | — | — |
| 2026-01-31 | BERG, AARON | President and CEO | Buy | 2,246 | — | — |
| 2026-01-31 | BERG, AARON | President and CEO | Buy | 1,933 | — | — |
| 2026-01-31 | BERG, AARON | President and CEO | Sale | 1,235 | $15.42 | $19043.70 |
| 2026-01-31 | BERG, AARON | President and CEO | Sale | 1,063 | $15.42 | $16391.46 |
| 2026-01-02 | PROVOOST, JONATHAN | EVP, Chief Legal Officer | Buy | 3,688 | — | — |
| 2026-01-02 | PROVOOST, JONATHAN | EVP, Chief Legal Officer | Buy | 3,688 | — | — |
| 2026-01-02 | PROVOOST, JONATHAN | EVP, Chief Legal Officer | Sale | 1,488 | $13.96 | $20772.48 |
| 2026-01-02 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 3,688 | — | — |
| 2026-01-02 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Buy | 3,688 | — | — |
| 2026-01-02 | KETCHUM, STEVEN B | EVP, Chief Scientific Officer | Sale | 2,041 | $13.96 | $28492.36 |
| 2026-01-02 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 3,688 | — | — |
| 2026-01-02 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Buy | 3,688 | — | — |
| 2026-01-02 | KEENAN, DAVID PAUL | EVP, Chief Operating Officer | Sale | 1,926 | $13.96 | $26886.96 |
| 2026-01-02 | FISHMAN, PETER L. | SVP, CFO | Buy | 2,447 | — | — |
| 2026-01-02 | FISHMAN, PETER L. | SVP, CFO | Buy | 2,447 | — | — |
| 2026-01-02 | FISHMAN, PETER L. | SVP, CFO | Sale | 1,356 | $13.96 | $18929.76 |
| 2025-08-01 | FISHMAN, PETER L. | SVP, CFO | Buy | 312 | — | — |
| 2025-08-01 | FISHMAN, PETER L. | SVP, CFO | Buy | 312 | — | — |
| 2025-08-01 | FISHMAN, PETER L. | SVP, CFO | Sale | 160 | $14.52 | $2323.20 |
| 2025-06-26 | BERG, AARON | President and CEO | Buy | 37,500 | — | — |
| 2025-06-26 | BERG, AARON | President and CEO | Buy | 75,000 | — | — |
| 2025-06-26 | BERG, AARON | President and CEO | Buy | 12,500 | — | — |
| 2025-06-26 | BERG, AARON | President and CEO | Buy | 75,000 | — | — |
| 2025-06-26 | BERG, AARON | President and CEO | Sale | 38,363 | $15.90 | $609971.70 |
| 2025-04-18 | SULLIVAN, DIANE E. | Director | Buy | 838 | — | — |
| 2025-04-18 | SULLIVAN, DIANE E. | Director | Buy | 838 | — | — |
| 2025-04-18 | SULLIVAN, DIANE E. | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | STERLING, LOUIS III | Director | Buy | 838 | — | — |
| 2025-04-18 | STERLING, LOUIS III | Director | Buy | 838 | — | — |
| 2025-04-18 | STERLING, LOUIS III | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | ODYSSEAS, KOSTAS D | Director | Buy | 838 | — | — |
| 2025-04-18 | ODYSSEAS, KOSTAS D | Director | Buy | 838 | — | — |
| 2025-04-18 | ODYSSEAS, KOSTAS D | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | O'CONNOR, OLIVER | Director | Buy | 838 | — | — |
| 2025-04-18 | O'CONNOR, OLIVER | Director | Buy | 838 | — | — |
| 2025-04-18 | O'CONNOR, OLIVER | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | HORN, KEITH | Director | Buy | 838 | — | — |
| 2025-04-18 | HORN, KEITH | Director | Buy | 838 | — | — |
| 2025-04-18 | HORN, KEITH | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | DIPAOLO, MARK | Director | Buy | 838 | — | — |
| 2025-04-18 | DIPAOLO, MARK | Director | Buy | 838 | — | — |
| 2025-04-18 | DIPAOLO, MARK | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | COHEN, PAUL | Director | Buy | 838 | — | — |
| 2025-04-18 | COHEN, PAUL | Director | Buy | 838 | — | — |
| 2025-04-18 | COHEN, PAUL | Director | Sale | 437 | $9.11 | $3981.07 |
| 2025-04-18 | BONFIGLIO, PATRICE EADON | Director | Buy | 838 | — | — |
Frequently asked questions
Are AMRN insiders buying or selling?
Over the transactions on record, AMRN insiders have been net buyers, with about $903763.67 in stock sold across 29 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at AMRN mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which AMRN insiders are selling the most?
Recent selling is concentrated in a few names. BERG, AARON accounts for the largest share on record, with about $645406.86 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.